XML 22 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Loss for the year $ (7,279) $ (19,977) $ (21,760)
Adjustments:      
Depreciation 186 197 201
Impairment loss 202
Finance income, net (3,726) (2,294) (843)
Share-based payments 582 1,875 2,412
Total adjustments (10,035) (20,199) (19,990)
Changes in assets and liabilities:      
Changes in other current assets 96 178 313
Changes in trade payables (2,076) 1,334 799
Changes in other payables (2,352) (1,076) 2,132
Changes in post-employment benefit liabilities (162) 11
Changes in assets and liabilities, total (4,332) 274 3,255
Net cash used in operating activities (14,367) (19,925) (16,735)
Cash flows from investing activities:      
Acquisition of subsidiary, net of cash acquired (see Note 4C) (3,549)
Proceed from other investments 187 875
Acquisition of intangible asset (202)
Decrease in short term deposits 2 15,803 19,658
Decrease in long term deposits 160
Interest received 320 755 324
Acquisition of fixed assets (3) (26)
Net cash provided by investing activities 509 13,881 19,914
Cash flows from financing activities:      
Proceeds from issuance of ADSs 5,809 1,563 1,498
ADS issuance expenses paid (556) (229) (152)
Proceeds from issuance of warrants and prefunded warrants 5,000
Proceeds from warrant inducement transaction 2,028
Warrants issuance expenses paid (280) (661)
Repayment of lease liability (183) (168) (165)
Interest paid (44) (56) (67)
Net cash provided by financing activities 6,774 5,449 1,114
Net increase (decrease) in cash and cash equivalents (7,084) (595) 4,293
Cash and cash equivalents at the beginning of the year 14,489 15,030 10,890
Effect of translation adjustments on cash and cash equivalents (4) 54 (153)
Cash and cash equivalents at end of the year $ 7,401 $ 14,489 $ 15,030